Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience

Fig. 4

Results of an ROC analysis to determine the appropriate reinfusion rate without AEs. a The ROC analysis for the appropriate reinfusion rate of volume. The area under the ROC curve was 0.743. The sensitivity and specificity for 125 mL/h were 55% and 88%, respectively, and those for 100 mL/h were 82% and 48%, respectively. b The ROC analysis for the appropriate reinfusion rate of the protein dose. The area under the ROC curve was 0.713. The sensitivity and specificity for 12.3 g/h were 73% and 60%, respectively, and those for 10.9 g/h were 86% and 53%, respectively. The labels in the graphs include the cut-off value (specificity, sensitivity) without the units

Back to article page